Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan

Japanese Journal of Infectious Diseases

Volumn 58, Issue 5, 2005, Pages 303-308

  Shigemura, Katsumi ^a   Tanaka, Kazushi ^a   Okada, Hiroshi ^b   Nakano, Yuzo ^a   Kinoshita, Shohiro ^c   Gotoh, Akinobu ^a   Arakawa, Soichi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFMETAZOLE; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; HABEKACIN; METICILLIN; MINOCYCLINE; OFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG CLASSIFICATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FREQUENCY ANALYSIS; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; UNIVERSITY HOSPITAL; URINALYSIS; URINARY TRACT INFECTION; URINE CATHETER; UROLOGY;

DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; JAPAN; METHICILLIN RESISTANCE; PSEUDOMONAS INFECTIONS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTIONS;

EID: 27744461592     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gastmeier, P., Kampf, G., Wischnewski, N., Hauer, T., Schulgen, G., Schumacher, M., Daschner, F. and Ruden, H. (1998): Prevalence of nosocomial infections in representative German hospitals. J. Hosp. Infect., 38, 37-49.
2. Barrett, S. P., Savage, M. A., Rebec, M. P., Guyot, A., Andrews, N. and Shrimpton, S. B. (1999): Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J. Antimicrob. Chemother., 44, 359-365.
3. Barrett, B. J. and Stephens, D. S. (1997): Urinary tract infection: an overview. Am. J. Med. Sci., 314, 245-249.
4. Dyer, I. E., Sankary T. M. and Dawson, J. A. (1998): Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West. J. Med., 169, 265-268.
5. Gupta, K., Sahm, D. F., Mayfield, D. and Stamm, W. E. (2001): Antimicrobial resistance among uropathogens that cause community acquired urinary tract infections in women: a nationwide analysis. Clin. Infect. Dis., 33, 89-94.
6. Neu, H. C. (1992): Urinary tract infections. Am. J. Med., 92 (Suppl. 4A), S63-S70.
7. Jones, R. N., Kirby, J. T., Beach, M. L., Biedenbach, D. J. and Pfaller, M. A. (2002): Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn. Microbiol. Infect. Dis., 43, 239-243.
8. Thomson, K. S., Sanders, W. E. and Sanders, C. C. (1994): USA resistance patterns among UTI pathogens. J. Antimicrob. Chemother., 33 (Suppl. A), 9-15.
9. Weber, G., Riesenberg, K., Schlaeffer, F., Peled, N., Borer, A. and Yagupsky, P. (1997): Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Isreal, 1991-1995. Eur. J. Clin. Microbiol. Infect. Dis., 16, 834-838.
10. Murakami, K., Aoki, Y., Miyaji, Y., Iwaoka, K., Tsuka, H., Saikawa, S., Wada, O., Gohbara, M., Akino, H., Mori, H., Takahashi, M., Ikeda, H., Oyama, N., Fujita, T., Miwa, Y., Moriyama, N., Nakamura, N., Suzuki, Y., Kanamaru, H. and Okada, K. (1995): Statistical studies on organized isolated from urinary tract infections during a ten-year period. Nishinihon J. Urol., 57, 1260-1264 (in Japanese).
11. Gales, A. C., Jones, R. N., Turnidge, J., Rennie, R. and Ramphal, R. (2001): Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis., 32 (Suppl. 2), S146-S155.
12. Low, D. E., Keller, N., Barth, A. and Jones, R. N. (2001): Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis., 32 (Suppl. 2), S133-S145.
13. Spencer, R. C. (1996): An 8 year microbe base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. J. Antimicrob. Chemother., 37, 295-301.
14. Wagenlehnera, F. M. E., Niemetzb, A., Dalhoffc, A. and Naber, K. G. (2002): A spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000. Int. J. Antimicrob. Agents, 19, 557-564.
15. Nasu, Y., Yamada, D., Ozawa, H., Nishimura, M., Hayashi, H., Maki, Y., Fujimoto, H., Nishitani, Y., Sakuramoto, K., Tsugawa, M., Kishi, M., Mizuno, A., Kumon, H. and Omori, H. (1998): Statistical studies of the relationship between organisms isolated from urinary tract infections and prescribed antimicrobial agents. Nishinihon J. Urol., 50, 557-566 (in Japanese).
16. Gales, A. C., Jones, R. N., Gordon, K. A., Sader, H. S., Wilke, W. W., Beach, M. L., Pfaller, M. A. and Doern, G. V. (2000): The SENTRY Study Group (Latin America). Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). J. Antimicrob. Chemother., 45, 295-303.
17. Jones, R. N., Kugler, K. C., Pfaller, M. A. and Winokur, P. L. (1999): The SENTRY Surveillance Group (North America). Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn. Microbiol. Infect. Dis., 35, 55-63.
18. Mathai, D., Jones, R. N., Pfaller, M. A. and the SENTRY Participant Group North America (2001): Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn. Microbiol. Infect. Dis., 40, 129-136.
19. Sader, H. S., Jones, R. N., Winokur, P. K., Pfaller, M. A., Doern, G. V., Barrett, T. and the SENTRY Study Group (Latin America) (1999): Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program, 1997. Clin. Microbiol. Infect., 5, 478-487.
20. Farrell, D. J., Morrissey, I., De Rubeis, D., Robbins, M. and Felmingham, D. (2003): A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J. Infect., 46, 94-100.
21. Turnidge, J., Bell, J., Biedenbach, D. J. and Jones, R. N. (2002): Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int. J. Antimicrob. Agents, 20, 10-17.
22. Kataoka, S., Tanimura, M., Yasuda, M., Kondo, K., Morioka, M. and Fujita, Y. (1992): Pathogen occurrence and antimicrobial susceptibility trends among urinary tract infection-the second report. Nishinihon J. Urol., 54, 812-821 (in Japanese).
23. Nagano, K. (2002): Urinary tract infection, practical management for major diseases in older patients. p. 189-192. Practical Guideline for Older Patient Medicine. Medical Practice, Tokyo, Japan.
24. Matumoto, T. (2001): Urinary tract infection. p. 76-82. Guideline of Use of Antibiotics. Japanese Association for Infectious Diseases/Japanese Society for Chemotherapy, Tokyo, Japan.
25. Gales, A. C., Sader, H. S., Jones, R. N. and SENTRY Participants Group (Latin America) (2002): Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn. Microbiol. Infect. Dis., 44, 289-299.
26. Arakawa, Y. (2002): Multiple-drug-resistant Pseudomonas aeruginosa. Infect. Dis. Wkly. Rep., 4(17), 9-13 (in Japanese).
27. Arakawa, Y. (2003): Multiple drug resistant gram negative rods and hospitalized infection measure. Urinary Tract Infection Conference Records 2003. p. 7.
28. Centers for Disease Control and Prevention (2002): National nosocominal infections surveillance report. Morb. Mortal. Wkly. Rep., 51, 565-567.